| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/06/2010 | US7750037 Antidepressant |
| 07/06/2010 | US7750030 Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning |
| 07/06/2010 | US7750024 [7-(1H-imidazol-1-yl)-6-nitro-2,3-dioxo-3,4-dihydroquinoxalin-1(2H)-yl]acetic acid, 2-[N-(4-chlorophenyl)-N-methylamino]-4H-pyrido[3,2-e]-1,3-thiazin-4-one, or 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)-quinoxaline; AMPA receptor antagonist; anticarcinogenic agents |
| 07/06/2010 | US7750023 Quinuclidine derivatives and medicinal compositions containing the same |
| 07/06/2010 | US7749987 treating with a mixture comprising nomegestrol acetate and estradiol valerate or estradiol; side effect reduction |
| 07/06/2010 | US7749971 Such as Hurler syndrome and Batten by administering an aminoglycosidesuch as gentamicin, G418, hygromycin B, paromomycin, tobramycin, lividomycin A, amikacin, sisomycin, or neomycin, optionally in combination with an enzyme effective for enzyme replacement therapy, a polyionic compound or gene therapy |
| 07/06/2010 | US7749960 An enteral composition or a pharmaceutical containing osteoprotegerin obtained from human or bovine milk or colostrum; preventing or treating disorders associated with bone metabolism and immune function |
| 07/06/2010 | US7749735 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta |
| 07/06/2010 | US7749718 Method for raising or isolating an antibody to DCRS5 |
| 07/06/2010 | US7749542 For preventing oral abuse of an oral opioid formulation; provides a negative, "aversive" experience when a large amount of the opioid, e.g., about 2-3 times the usually prescribed dose, is taken by or administered to a physically dependent subject |
| 07/06/2010 | US7749522 Organ arrest, protection and preservation |
| 07/06/2010 | US7749499 Immunoglobulin for use in diagnosis, prevention and treatment of neisserial infection; immunootherapeutics |
| 07/06/2010 | CA2522761C Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 07/06/2010 | CA2454863C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 07/06/2010 | CA2437109C Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 07/06/2010 | CA2427429C Acylaminoalkyl-substituted benzenesulfonamide derivatives,their preparation, their use and pharmaceutical preparations comprising them |
| 07/06/2010 | CA2415962C Valsartan salts |
| 07/06/2010 | CA2382129C Novel derivatives of flavones, xanthones and coumarins |
| 07/06/2010 | CA2359462C Pyrazole compounds and uses thereof |
| 07/06/2010 | CA2333188C Multiparticulate pharmaceutical form with programmed and timed release and preparation method |
| 07/06/2010 | CA2298864C Chemical modification of proteins to improve biocompatibility and bioactivity |
| 07/06/2010 | CA2288059C Method of treating malignancies |
| 07/01/2010 | WO2010075263A2 Compounds and methods for enhancing erythropoiesis |
| 07/01/2010 | WO2010074284A1 Pyrazolopyrimidine compound |
| 07/01/2010 | WO2010074271A1 Therapeutic agent for diabetes |
| 07/01/2010 | WO2010074244A1 Isoquinoline derivative |
| 07/01/2010 | WO2010074220A1 Composition containing sesamins and epigallocatechin gallate |
| 07/01/2010 | WO2010074193A1 Novel bicyclic heterocyclic compound |
| 07/01/2010 | WO2010074192A1 Diagnosis and treatment of cancer using anti-lgr7 antibody |
| 07/01/2010 | WO2010074110A1 Method for producing cyclic aminobenzoic acid derivative |
| 07/01/2010 | WO2010074089A1 Indanyl compounds |
| 07/01/2010 | WO2010073719A1 Eg5 inhibitor |
| 07/01/2010 | WO2010073667A1 Ultraviolet rays protective agent |
| 07/01/2010 | WO2010073544A1 Method for testing risk of coronary artery diseases |
| 07/01/2010 | WO2010072774A2 Agent for treating stenosis of the spinal canal |
| 07/01/2010 | WO2010072684A1 Norrin in the treatment of diseases associated with an increased tgf-beta activity |
| 07/01/2010 | WO2010033822A3 Therapeutic and diagnostic strategies |
| 07/01/2010 | US20100168187 Therapeutic combination |
| 07/01/2010 | US20100168166 Method of Providing An Antihistaminic Effect in a Hepatically Impaired Patient |
| 07/01/2010 | US20100168139 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/01/2010 | US20100168109 Pharmaceutical compositions of 1,2,4-oxadiazole benzoic acid and their use for the treatment of disease |
| 07/01/2010 | US20100168101 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| 07/01/2010 | US20100168052 Treatment of EBV and KHSV Infection and Associated Abnormal Cellular Proliferation |
| 07/01/2010 | US20100168048 Method of Stabilizing S-Adenosyl-L-Methionine and Stabilized Composition |
| 07/01/2010 | US20100168034 Peptide having cell membrane penetrating activity |
| 07/01/2010 | US20100168032 Smart Pro-Drugs of Serine Protease Inhibitors |
| 07/01/2010 | US20100168031 Lat peptides and their use in assays for identifying immunosuppressants |
| 07/01/2010 | US20100167998 Growth-stimulating polypeptides for use in fish and crustaceans |
| 07/01/2010 | US20100167393 Modified human thymic stromal lymphopoietin |
| 07/01/2010 | US20100167275 Potassium channel mutants of the yeast Saccharomyces cerevisiae and their use for screening eukaryotic potassium channels |
| 07/01/2010 | US20100166864 Matrix-based pulse release pharmaceutical formulation |
| 07/01/2010 | US20100166821 Anti-Inflammatory, Radioprotective, and Longevity Enhancing Capabilities of Cerium Oxide Nanoparticles |
| 07/01/2010 | US20100166808 Method of Facilitating Intracellular Uptake or Transcellular Transport of Cargo Using Nanocarriers Containing Optimal Surface Densities of Integrin-Specific Ligands |
| 07/01/2010 | US20100166807 Methods for reducing the incidence of mastitis |
| 07/01/2010 | US20100166760 Methods of reducing phosphate absorption |
| 07/01/2010 | US20100166725 Human Cystathionine beta-Synthase Variants and Methods of Production Thereof |
| 07/01/2010 | US20100166719 Hair growth method |
| 07/01/2010 | US20100166716 Colony-forming unit cell of human chorion and method to obtain and use thereof |
| 07/01/2010 | US20100166656 Diagnostic And Radiotherapeutic Contrast Agents And Process For Their Preparation |
| 07/01/2010 | CA2748990A1 Diagnosis and treatment of cancer using anti-lgr7 antibody |
| 07/01/2010 | CA2748251A1 Novel bicyclic heterocyclic compound |
| 07/01/2010 | CA2748250A1 Indanyl compounds |
| 07/01/2010 | CA2748163A1 Agents for treating spinal canal stenosis |
| 07/01/2010 | CA2747996A1 Compounds and methods for enhancing erythropoiesis |
| 07/01/2010 | CA2747795A1 Isoquinoline derivative |
| 06/30/2010 | EP2202245A1 Method of modifying isoelectric point of antibody via amino acid substitution in cdr |
| 06/30/2010 | EP2202243A2 Antigen binding domains from fish |
| 06/30/2010 | EP2202241A2 Therapeutic compounds and methods for modulating V3, a versican isoform |
| 06/30/2010 | EP2202240A1 Compound |
| 06/30/2010 | EP2202235A1 Bis(trimethylsilyl)phenyl compound or salt thereof, and use thereof |
| 06/30/2010 | EP2202233A1 Method for producing pyrazole fused ring derivative |
| 06/30/2010 | EP2202231A1 2,3-dihydroiminoisoindole derivative |
| 06/30/2010 | EP2202229A1 Novel preparation for external use |
| 06/30/2010 | EP2202228A1 Amide compounds and use of the same |
| 06/30/2010 | EP2202216A1 Spiro-ring compound and use thereof for medical purposes |
| 06/30/2010 | EP2201964A2 Formoterol superfine formulation |
| 06/30/2010 | EP2201947A2 Use of SAHA for treating mesothelioma |
| 06/30/2010 | EP2201946A1 Pai-1 production inhibitor |
| 06/30/2010 | EP2200596A1 Method of treating gaucher disease |
| 06/30/2010 | EP1545548B1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 06/30/2010 | EP1465616B1 Treatment of statin side effects using uridine derivatives |
| 06/30/2010 | EP1368323B1 Pyrimidine matrix metalloproteinase inhibitors |
| 06/30/2010 | EP1366760B1 Tablets quickly disintegrated in oral cavity |
| 06/30/2010 | EP1366044B1 8-{4-[3-(5-fluoro-1h-indol-3-yl)propyl ]-1-piperazinyl} -2-methyl-2h-1, 4-benzoxazin-3(4h)-one methanesulfonate with high affinity for the dopamine d2 receptor and the serotonin reuptake site |
| 06/30/2010 | EP1291016B1 New use of modafinil and the d/l enantiomer |
| 06/30/2010 | EP1284727B1 Intracorporeal medicaments for photodynamic treatment of disease |
| 06/30/2010 | EP1278735B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 06/30/2010 | EP1036164B1 Chemokine alpha-5 |
| 06/30/2010 | CN1836568B Wild rose health food and preparation method thereof |
| 06/30/2010 | CN1533276B Use of thiazole derivatives for preparing medicine for protecting mitochondria |
| 06/30/2010 | CN101765427A Improving memory in subjects with mini-mental state examination of 24-26 |
| 06/30/2010 | CN101760377A Wine for reducing internal heat and manufacturing method thereof |
| 06/30/2010 | CN101760333A Candle with healthcare function on lymph |
| 06/30/2010 | CN101759686A Synthesizing method and application of 2-substituted aryl-1-substituted benzyl benzimidazole compound |
| 06/30/2010 | CN101757592A Traditional Chinese medicine composition for treating spontaneous perspiration |
| 06/30/2010 | CN101757578A Traditional Chinese medicine for treating hands and feet coolness |
| 06/30/2010 | CN101757564A Traditional Chinese medicine composition for treating liver depression and qi stagnation |
| 06/30/2010 | CN101757525A Traditional Chinese medicine preparation for treating hiccough |
| 06/30/2010 | CN101757514A Traditional Chinese medicine for preventing and treating self-biting disease of pets |
| 06/30/2010 | CN101757495A Traditional Chinese medicine for antidiarrhea and antidehydration |